Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias

BACKGROUND AND AIM: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a fatal condition with no established treatment. Intravenous immunoglobulin (IVIG) is a unique therapy with both anti-inflammatory and anti-infective effects. Therefore, we hypothesized that IVIG may have a positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Higo, Hisao, Ichikawa, Hirohisa, Nakamura, Naoki, Fujii, Masanori, Matsuoka, Katsuhiro, Seki, Shoko, Wada, Takamasa, Suzaki, Noriyuki, Nagata, Takuya, Arakawa, Yukako, Mori, Yoshihiro, Marukawa, Masaomi, Kiura, Katsuyuki, Maeda, Yoshinobu, Miyahara, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798342/
https://www.ncbi.nlm.nih.gov/pubmed/36533600
http://dx.doi.org/10.36141/svdld.v39i4.13682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798342/
https://www.ncbi.nlm.nih.gov/pubmed/36533600
http://dx.doi.org/10.36141/svdld.v39i4.13682

Ejemplares similares